Cost-Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccine in the United States
Value Health
.
2014 Nov;17(7):A679.
doi: 10.1016/j.jval.2014.08.2528.
Epub 2014 Oct 26.
Authors
P T De Boer
1
,
R J Pitman
2
,
B Macabeo
3
,
A Chit
4
,
M J Postma
1
,
P Crépey
5
Affiliations
1
University of Groningen, Groningen, The Netherlands.
2
ICON Clinical Research, Oxford, UK.
3
Sanofi Pasteur, Lyon, France.
4
Sanofi Pasteur, Toronto, ON, Canada.
5
EHESP Rennes, Paris, France.
PMID:
27202508
DOI:
10.1016/j.jval.2014.08.2528
No abstract available